clinical trial · NCT06548360
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo
NonSegmental VitiligoRuxolitinib CreamVehicle Cream
brief summary
The purpose of this study is to to evaluate the safety and efficacy of ruxolitinib cream in pediatric participants with nonsegmental vitiligo.
started
Jan 24, 2025
primary completion
Aug 10, 2026
completion
Mar 13, 2027
last updated
Jul 23, 2026
official title
A Phase 3, Randomized, Double-Blind, Safety, and Efficacy Study of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol